Search for: "Aventis Pharma SA"
Results 1 - 20
of 31
Sorted by Relevance
|
Sort by Date
2 Oct 2011, 8:43 pm
The case involved an application for interlocutory injunctive relief by the owner of Australian patent no. 666859 (the patent), Aventis Pharma SA, and its exclusive licensees, to restrain generic pharmaceutical companies Interpharma and Hospira from threatened infringement. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
10 Aug 2010, 8:44 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
31 Oct 2008, 11:53 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Feb 2009, 5:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 Aug 2009, 8:11 am
., Baxter Healthcare SA v. [read post]
3 Aug 2011, 3:31 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
25 Oct 2008, 12:03 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 Mar 2010, 2:30 am
Astellas Pharma US, Inc. [read post]
21 May 2010, 2:32 am
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
26 May 2007, 11:26 pm
Bristol-Myers Squibb and Sa nofi-Aventis, which co-market the widely used drug, defended the patent from a challenge by Canadian generic drugmaker Apotex, which briefly flooded the market with copycat Plavix tablets last summer. [read post]
3 Jan 2019, 5:21 am
C00716606/01 (for the active ingredient sevelamer) and their exclusive licensee Sanofi-Aventis (Suisse) SA enforced their SPC against Swiss pharmaceutical company Salmon Pharma GmbH which had started marketing a generic version of Sanofi-Aventis’ medicament Renvela® containing the active ingredient sevelamer carbonate. [read post]
22 Feb 2008, 1:30 pm
In a crushing blow to consumers, on Thursday, February 21st, the United States Supreme Court again sided with big pharmaceutical medical device makers. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
17 Jan 2008, 10:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:The European antitrust raids on Pfizer, AstraZeneca, Glaxo, Sanofi-Aventis: (IP Law360), (Wall Street Journal Health Blog), (IAM), (IPEG), (SmartBrief), (In the pipeline),Hasbro and Mattel alleged trade mark infringement and demand shut down of Scrabulous, a free online gaming site allowing users to play a version of… [read post]
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
28 Apr 2008, 11:00 am
: Art, access and the public domain after Bridgeman v Corel’ – 29 April, New York City: (creativecommons.org), (Public Knowledge) US: ACI ‘Paragraph IV disputes’ conference – 30 April – 1 May, New York City: (Orange Book Blog) Pharma & Biotech Pharma & Biotech - General Canada: Patented Medicine Prices Review Board (PMPRB) departs from its guidelines in determining price in recent decision:… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
22 Feb 2008, 6:00 pm
: (Class 46),Paper on virtual trade marks: (Innovationpartners)Global - PatentsPatents as intangible asset partitions: (Patent Prospector),Selling out – exiting a patent dispute by company sale: (IP ThinkTank),IBM leads from the front and puts green patents on the side of the angels: (IAM),Innovation and the university-industry interface: (Securing Innovation), Thomson’s ‘Patent focus report for 2008’ covering patent activity in China , Europe, Japan , India… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
